Sign in with Google. Opens in new tab
bullish
Classys (214150 KS): Record High Sales in 3Q24; Volnewmer Led Performance Growth; US Launch Begins
328 Views12 Nov 2024 17:05
SUMMARY
- In 3Q24, Classys (214150 KS) reported revenue of KRW59B, up 23% YoY. Better-than-expected overseas demand of Volnewmer and record high consumables revenue in domestic market led the performance growth.
- Profitability decline in 3Q24 was anticipated. Profitability is expected to improve in coming quarters. With the current momentum, Classys is well-positioned to beat 2024 sales guidance of KRW225B.
- Strong marketing capability of the U.S. marketing partner and encouraging response in the launch meeting enhance conviction on the growth potential of Volnewmer in the U.S. market.
Related Insights
More »- Classys (214150 KS): Solid Start to 2025; Global Expansion Continues; Stake Sale Overhang to Remain
- Classys: Block Deal Sale of 6% By Bain Capital Raises Overhang Concerns
- Classys (214150 KS): 2024 Sales Beat Guidance; New Record Sales Target for 2025
- Classys (214150 KS): Record High Sales in 3Q24; Volnewmer Led Performance Growth; US Launch Begins
- Classys (214150 KS): Solid 2Q24 Result Fuelled by Strong Demand for Aesthetic Medical Devices
Trending Collections
More »Trending Insights
More »- Gold Miners ETF (GDX US): Impact of Benchmark Change - Update
- Gemlife (GLF AU): Index Inclusions Start Later This Year
- SingPost (SPOST SP): More Non-Core Divestments - Slowly But Surely
- Why Is LG CNS One of the Hottest Stocks in Korea in the Past One Month? Answer: Stablecoin Platform
- Nikkei 225 Stock Average Rebalancing – June 2025
Top Unpaywalled Insights
More »Loading
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Top Quartile
Tina Banerjee
Global Healthcare Analyst
Price Chart(Sign Up to Access)
- Classys (214150 KS): Solid Start to 2025; Global Expansion Continues; Stake Sale Overhang to Remain03 Jun 2025
- Classys: Block Deal Sale of 6% By Bain Capital Raises Overhang Concerns18 May 2025
- Classys (214150 KS): 2024 Sales Beat Guidance; New Record Sales Target for 202518 Feb 2025
- Classys (214150 KS): Record High Sales in 3Q24; Volnewmer Led Performance Growth; US Launch Begins12 Nov 2024
- Classys (214150 KS): Solid 2Q24 Result Fuelled by Strong Demand for Aesthetic Medical Devices18 Aug 2024
- Classys (214150 KS): Beautiful Journey Continues; Record High Revenue and Operating Profit in 1Q2409 May 2024
- Classys (214150 KS): 2023 Sales Beat Guidance to Reach Record High; Stellar Performance to Continue01 Mar 2024
x